- DEMENTIA RESEARCHER - https://www.dementiaresearcher.nihr.ac.uk -

LIVE STREAM – Genetic therapies in neurodegeneration: cohorts, targets and approaches

The Leonard Wolfson Experimental Neurology Centre (LWENC) is a a new experimental neurology centre, at University College London aimed at the understanding and treatment of neurodegenerative diseases. On the 25th May they are hosting a unique seminar with world class speakers. This event is being live streamed at the following location starting at 9.40am and finishing at 1pm.

Watch the Live Stream – 25th May 9.40am [1]

 

The live stream will also be available for viewing after the event.

Programme

9:40: Welcome and setting the sceneNick Fox

Genetic discoveries and Queen Square: advances and opportunitiesJohn Hardy

Introduction of keynote speakerSarah Tabrizi

10:00: Keynote lectureFrank Bennett

Dr. Bennett is Senior Vice President of Research at Ionis Pharmaceuticals. He is responsible for preclinical antisense drug discovery and antisense technology research. Dr. Bennett is also the franchise leader for the Neurological Programs at Ionis. He is one of the founding members of the Company. Dr. Bennett has been involved in the development of antisense oligonucleotides as therapeutic agents, including research on the application of oligonucleotides for inflammatory, neurodegenerative diseases and cancer, oligonucleotide delivery, pharmacokinetics and medicinal chemistry. Dr. Bennett has published more than 175 papers in the field of antisense research and development and has more than 150 issued U.S. patents.

11:00: Refreshment Break

11:25: Huntington’s disease, results from the IONIS HTT Rx CS1 study – first HTT lowering clinical trial, Sarah Tabrizi

11:40: Charcot-Marie-Tooth disease type 1A, trials and developing cohortsMary Reilly

11:55: Alzheimer’s disease & Familial Alzheimer’s disease, introduction to cohortsCatherine Mummery

12:10: Challenge of Antisense oligonucleotide therapy for Familial Alzheimer’s diseaseBart de Strooper

12:25: Developing cohorts in Frontotemporal dementia, Jonathan Rohrer

12:40: Developing cohorts in Parkinson’s disease and progressive supranuclear palsyHuw Morris

12:55: Closing remarksMike Hanna

Hosted by Leonard Wolfson Experimental Neurology Centre and UK Dementia Research Institute at UCL.

Join us in the debate: #UCLDementiaSeminars [2] #QSCNMD [3]